188 related articles for article (PubMed ID: 19697440)
1. Intraperitoneal immunotherapy to prevent peritoneal carcinomatosis in patients with advanced gastrointestinal malignancies.
Ströhlein MA; Heiss MM
J Surg Oncol; 2009 Sep; 100(4):329-30. PubMed ID: 19697440
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal immunotherapy of peritoneal carcinomatosis.
Freedman RS; Lenzi R; Kudelka AP; Lawrence DD; Rosenblum M; Platsoucas CD
Cytokines Cell Mol Ther; 1998 Jun; 4(2):121-40. PubMed ID: 9681251
[TBL] [Abstract][Full Text] [Related]
3. Laparoscopic intraperitoneal chemohyperthermia (IPCH) for gastrointestinal malignancies: indications and results.
Chouillard E
Minerva Chir; 2008 Dec; 63(6):497-509. PubMed ID: 19078882
[TBL] [Abstract][Full Text] [Related]
4. [Long-term results of peritonectomy on the patients with peritoneal carcinomatosis].
Yonemura Y; Ikeno T; Shinbo M; Maejima S; Hagiwara A; Endou Y; Masahiro M; Ogura S; ;
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1926-30. PubMed ID: 18219855
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial.
Ströhlein MA; Lordick F; Rüttinger D; Grützner KU; Schemanski OC; Jäger M; Lindhofer H; Hennig M; Jauch KW; Peschel C; Heiss MM
Onkologie; 2011; 34(3):101-8. PubMed ID: 21358214
[TBL] [Abstract][Full Text] [Related]
6. The current status of immunotherapy in peritoneal carcinomatosis.
Ströhlein MA; Heiss MM; Jauch KW
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1019-27. PubMed ID: 27530056
[TBL] [Abstract][Full Text] [Related]
7. Natural history of the neoplastic locoregional disease: clinical and pathological patterns.
Cagol PP; Pasqual E; Bacchetti S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):1-4. PubMed ID: 16767897
[TBL] [Abstract][Full Text] [Related]
8. Management of peritoneal carcinomatosis secondary to metastatic cancer of unknown primary in men.
Mugerwa S; Lekharaju V; Kiire CF
Eur J Cancer Care (Engl); 2009 Jan; 18(1):22-7. PubMed ID: 19016832
[TBL] [Abstract][Full Text] [Related]
9. Prevention of peritoneal carcinomatosis from human gastric cancer cells by adjuvant-type intraperitoneal immunotherapy in a SCID mouse model.
Piso P; Aselmann H; von Wasielewski R; Dahlke MH; Klempnauer J; Schlitt HJ
Eur Surg Res; 2003; 35(6):470-6. PubMed ID: 14593230
[TBL] [Abstract][Full Text] [Related]
10. Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis.
Ströhlein MA; Siegel R; Jäger M; Lindhofer H; Jauch KW; Heiss MM
J Exp Clin Cancer Res; 2009 Feb; 28(1):18. PubMed ID: 19216794
[TBL] [Abstract][Full Text] [Related]
11. Potential role of tumor vaccines in GI malignancies.
Laheru DA; Jaffee EM
Oncology (Williston Park); 2000 Feb; 14(2):245-56; discussion 259-60, 265. PubMed ID: 10736811
[TBL] [Abstract][Full Text] [Related]
12. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence.
Lefevre JH; Elias DM
Cancer J; 2009; 15(3):200-3. PubMed ID: 19556905
[TBL] [Abstract][Full Text] [Related]
14. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
15. Morbidity and mortality of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis.
Spiliotis J; Rogdakis A; Vaxevanidou A; Datsis A; Zacharis G; Christopoulou A
J BUON; 2009; 14(2):259-64. PubMed ID: 19650176
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.
Wei GX; Du Y; Zhou YW; Li LJ; Qiu M
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):851-861. PubMed ID: 36107723
[TBL] [Abstract][Full Text] [Related]
17. Wistar Symposium on Immunodiagnosis and Immunotherapy with CO17-1A MAb in Gastrointestinal Cancer. April 2-3, 1986, Philadelphia, PA.
Hybridoma; 1986 Jul; 5 Suppl 1():S1-187. PubMed ID: 3744375
[No Abstract] [Full Text] [Related]
18. [The role of intraperitoneal macrophages in the progression of peritoneal carcinomatosis from gastric cancer].
Yamaguchi T; Fushida S; Tsukada T; Kinoshita J; Oyama K; Watanabe T; Okamoto K; Nakamura K; Ninomiya I; Fujimura T; Ohta T
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1270-2. PubMed ID: 25335714
[TBL] [Abstract][Full Text] [Related]
19. Management of peritoneal carcinomatosis from colorectal cancer: current state of practice.
Cotte E; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O
Cancer J; 2009; 15(3):243-8. PubMed ID: 19556911
[TBL] [Abstract][Full Text] [Related]
20. Management of colorectal liver metastases in patients with peritoneal carcinomatosis.
Izzo F; Piccirillo M; Palaia R; Albino V; Di Giacomo R; Mastro AA
J Surg Oncol; 2009 Sep; 100(4):345-7. PubMed ID: 19697443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
